• Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial.
  Margolis DA, Brinson CC, Smith GH,  et al   
  Lancet Infect Dis. 2015 Jul 17
  Abstract
• Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection.
  Yoshinaga T, Kobayashi M, Seki T, et al
  Antimicrob Agents Chemother. 2015 Jan;59(1):397-406
  Abstract
• Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults.
  Spreen W, Williams P, Margolis D,  et al
  J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):487-92.
  Abstract
• A WEEK-IN-REVIEW FEATURED REOIRT
  Antiviral characteristics of GSK1265744, an HIV integrase inhibitor dosed orally or by long-acting injection.
  Yoshinaga T, Kobayashi M, Seki T,  et al
  Antimicrob Agents Chemother. 2014 Nov 3
  Abstract
• GSK1265744 Pharmacokinetics in Plasma and Tissue Following Single-Dose Long-Acting (LA) Injectable Administration in Healthy Subjects.
  Spreen W, Ford SL, Chen S,  et al
  J Acquir Immune Defic Syndr. 2014 Aug 19
  Abstract
• Parenteral patent drug S/GSK1265744 has the potential to be an effective agent in pre-exposure prophylaxis against HIV infection.
  Taha H, Morgan J, Das A, Das S.
  Recent Pat Antiinfect Drug Discov. 2013 Dec;8(3):213-8.
  Abstract
• Effects of Etravirine on the Pharmacokinetics of the Integrase Inhibitor S/GSK1265744.
  Ford SL, Gould E, Chen S, et al 
  Antimicrob Agents Chemother. 2012 Oct 31.
  Abstract
• Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.
  Andrews CD, Spreen WR, Mohri H,  et al
  Science. 2014 Mar 7;343(6175):1151-4.
  Abstract
  Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor.
  Spreen W, Min S, Ford SL, et al
  HIV Clin Trials. 2013 Sep-Oct;14(5):192-203
  Abstract
• FULL-TEXT ARTICLE
  Long-acting injectable antiretrovirals for HIV treatment and prevention.
  Spreen WR, Margolis DA, Pottage JC Jr.
  Curr Opin HIV AIDS. 2013 Nov;8(6):565-71
  Paper
• FULL-TEXT ARTICLE
  Lack of pharmacokinetic interaction between rilpivirine and integrase inhibitors dolutegravir and GSK1265744.
  Ford SL, Gould E, Chen S,  et al
  Antimicrob Agents Chemother. 2013 Nov;57(11):5472-7
  Paper
• Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).
  Johns BA, Kawasuji T, Weatherhead JG, et al
  J Med Chem. 2013 Jul 25;56(14):5901-16
  Abstract
• FULL-TEXT ARTICLE
  Effects of etravirine on the pharmacokinetics of the integrase inhibitor S/GSK1265744.
  Ford SL, Gould E, Chen S,  et al
  Antimicrob Agents Chemother. 2013 Jan;57(1):277-80.
  Paper
   

GSK-1265744 (Cabotegravir)